Business Description
This fund targets companies around the world that are expected to benefit from breakthroughs in genetics and biotechnology. Rather than holding every stock in its benchmark index, it selects a representative sample that closely mirrors the overall risk and return profile of that index. Investors should be aware that the fund is non-diversified, meaning it may hold a relatively small number of positions.
